Finance

Lists
ECVT:NYSE
Ecovyst Inc
$10.44
-1.88%
(-0.20) 1D
Sep 18, 1:59:11 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ECVT...
Open
$10.64
High
$10.64
Low
$10.38
Mkt. cap
1.14B
Avg. vol.
1.32M
Volume
385.12K
52-wk high
$15.08
52-wk low
$7.41
EPS
-$0.54
Beta
1.07
Shares outstanding
109.47M
No. of employees
617
Open
$10.64
High
$10.64
Low
$10.38
Mkt. cap
1.14B
Avg. vol.
1.32M
Volume
385.12K
52-wk high
$15.08
52-wk low
$7.41
EPS
-$0.54
Beta
1.07
Shares outstanding
109.47M
No. of employees
617
News stories
From web sources and news partners
About Ecovyst Inc
CEOJames F. Gentilcore
Employees617
FoundedAug 7, 2015
Headquarters-
SectorCommodity chemical
Websiteecovyst.com
Analyst ratings
Based on 5 analysts giving stock ratings to ECVT in the past 3 months
Strong buy
Buy
4
Hold
1
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for ECVT in the last 3 months.
Highest
Current $10.44
$16.00 (+53.26%)
Average
$14.80 (+41.76%)
Lowest
$13.00 (+24.52%)
Analyst
Recommendation
Action
Price target
Projected
Date
David C Silver
Freedom Capital Markets
Buy
Maintained
$15.00
+43.7%
09/16/2026
David Begleiter
Deutsche Bank
Buy
Maintained
$14.00
+34.1%
09/01/2026
John McNulty
BMO Capital
Buy
Reiterated
$16.00
+53.3%
08/13/2026
Hamed Khorsand
BWS Financial
Buy
Maintained
$16.00
+53.3%
08/06/2026
Patrick Cunningham
Citi
Hold
Maintained
$13.00
+24.5%
08/06/2026
Unknown Analyst
Freedom Capital Markets
Buy
Initiated
$15.00
+43.7%
06/29/2026
Aleksey Yefremov
KeyBanc
Buy
Maintained
$14.00
+34.1%
02/27/2026
Last report
Aug 5, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
$0.21 / $0.19
+12.75%beat
Revenue / Est. (USD)
249.96M / 236.85M
+5.53%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
204.91M
199.43M
214.95M
249.96M
Cost of goods sold
152.83M
152.68M
178.54M
200.12M
Cost of revenue
152.83M
152.68M
178.54M
200.12M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
15.67M
16.26M
19.05M
17.30M
Operating expense
18.42M
21.82M
22.65M
27.79M
Total operating expenses
171.25M
174.50M
201.18M
227.91M
Operating income
33.66M
24.93M
13.77M
22.05M
Other non operating income
2.72M
-6.28M
271.00K
221.00K
EBT including unusual items
20.57M
8.17M
9.34M
14.89M
EBT excluding unusual items
25.96M
15.89M
10.49M
18.51M
Income tax expense
20.20M
-476.00K
3.59M
4.19M
Effective tax rate
98.19%
-5.82%
38.45%
28.16%
Other operating expenses
2.75M
5.55M
3.59M
10.49M
Net income
-79.26M
5.74M
4.31M
7.86M
Net profit margin
-38.68%
2.88%
2.01%
3.15%
Earnings per share
0.19
0.28
0.11
0.21
Interest and investment income
-
-
-
-
Interest expense
-10.41M
-3.14M
-3.54M
-3.76M
Net interest expenses
-10.41M
-3.14M
-3.54M
-3.76M
Depreciation and amortization charges
-
-
-
-
EBITDA
44.60M
45.52M
34.26M
41.67M
Gain or loss from assets sale
-
1.32M
363.00K
2.26M
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps